The impact of clopidogrel on plasma-soluble CD40 ligand levels in systemic lupus erythematosus patients: the CLOPUS phase I/II pilot study - Archive ouverte HAL Access content directly
Journal Articles Joint Bone Spine Year : 2021

The impact of clopidogrel on plasma-soluble CD40 ligand levels in systemic lupus erythematosus patients: the CLOPUS phase I/II pilot study

, , , , , , , , (1) , ,
1
Guillaume Vial
Noémie Gensous
  • Function : Author
Hélène Savel
  • Function : Author
Christophe Richez
Estibaliz Lazaro
Marie-Elise Truchetet
Fabrice Bonnet
  • Function : Author
Isabelle Pellegrin
  • Function : Author
Rodolphe Thiébaut
Patrick Blanco
Pierre Duffau
Not file

Dates and versions

hal-03142764 , version 1 (16-02-2021)

Identifiers

Cite

Guillaume Vial, Noémie Gensous, Hélène Savel, Christophe Richez, Estibaliz Lazaro, et al.. The impact of clopidogrel on plasma-soluble CD40 ligand levels in systemic lupus erythematosus patients: the CLOPUS phase I/II pilot study. Joint Bone Spine, 2021, 88 (2), pp.105097. ⟨10.1016/j.jbspin.2020.105097⟩. ⟨hal-03142764⟩
12 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More